Neubig RR[au] - Search Results

Year	Number of Results
1975	1
1979	2
1980	1
1981	1
1982	1
1985	2
1986	2
1987	1
1988	3
1989	4
1990	4
1991	2
1992	2
1993	4
1994	9
1995	1
1996	3
1997	3
1998	4
1999	2
2000	6
2001	8
2002	11
2003	10
2004	9
2005	7
2006	6
2007	12
2008	9
2009	14
2010	14
2011	7
2012	8
2013	12
2014	10
2015	6
2016	8
2017	11
2018	7
2019	12
2020	4
2021	8
2022	5

1

Retraction: Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes.

Feng H, Larrivee CL, Demireva EY, Xie H, Leipprandt JR, Neubig RR. Feng H, et al. Among authors: neubig rr. PLoS One. 2021 Oct 14;16(10):e0258912. doi: 10.1371/journal.pone.0258912. eCollection 2021. PLoS One. 2021. PMID: 34648593 Free PMC article. No abstract available.

2

RAC1^P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance.

Lionarons DA, Hancock DC, Rana S, East P, Moore C, Murillo MM, Carvalho J, Spencer-Dene B, Herbert E, Stamp G, Damry D, Calado DP, Rosewell I, Fritsch R, Neubig RR, Molina-Arcas M, Downward J. Lionarons DA, et al. Among authors: neubig rr. Cancer Cell. 2019 Jul 8;36(1):68-83.e9. doi: 10.1016/j.ccell.2019.05.015. Epub 2019 Jun 27. Cancer Cell. 2019. PMID: 31257073 Free PMC article.

3

Community guidelines for GPCR ligand bias: IUPHAR review 32.

Kolb P, Kenakin T, Alexander SPH, Bermudez M, Bohn LM, Breinholt CS, Bouvier M, Hill SJ, Kostenis E, Martemyanov KA, Neubig RR, Onaran HO, Rajagopal S, Roth BL, Selent J, Shukla AK, Sommer ME, Gloriam DE. Kolb P, et al. Among authors: neubig rr. Br J Pharmacol. 2022 Feb 1. doi: 10.1111/bph.15811. Online ahead of print. Br J Pharmacol. 2022. PMID: 35106752 Review.

4

COVID-19-A Theory of Autoimmunity Against ACE-2 Explained.

McMillan P, Dexhiemer T, Neubig RR, Uhal BD. McMillan P, et al. Among authors: neubig rr. Front Immunol. 2021 Mar 23;12:582166. doi: 10.3389/fimmu.2021.582166. eCollection 2021. Front Immunol. 2021. PMID: 33833750 Free PMC article. Review.

5

A mechanistic review on GNAO1-associated movement disorder.

Feng H, Khalil S, Neubig RR, Sidiropoulos C. Feng H, et al. Among authors: neubig rr. Neurobiol Dis. 2018 Aug;116:131-141. doi: 10.1016/j.nbd.2018.05.005. Epub 2018 May 24. Neurobiol Dis. 2018. PMID: 29758257 Review.

6

Mice with an RGS-insensitive Gα_i2 protein show growth hormone axis dysfunction.

Omouessi ST, Leipprandt JR, Akoume MY, Charbeneau R, Wade S, Neubig RR. Omouessi ST, et al. Among authors: neubig rr. Mol Cell Endocrinol. 2021 Feb 5;521:111098. doi: 10.1016/j.mce.2020.111098. Epub 2020 Dec 2. Mol Cell Endocrinol. 2021. PMID: 33278490

7

Analyzing binding data.

Motulsky HJ, Neubig RR. Motulsky HJ, et al. Among authors: neubig rr. Curr Protoc Neurosci. 2010 Jul;Chapter 7:Unit 7.5. doi: 10.1002/0471142301.ns0705s52. Curr Protoc Neurosci. 2010. PMID: 20578035

8

Mind your salts: when the inactive constituent isn't.

Neubig RR. Neubig RR. Mol Pharmacol. 2010 Oct;78(4):558-9. doi: 10.1124/mol.110.067645. Epub 2010 Jul 22. Mol Pharmacol. 2010. PMID: 20651116 Review.

9

Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells.

Misek SA, Appleton KM, Dexheimer TS, Lisabeth EM, Lo RS, Larsen SD, Gallo KA, Neubig RR. Misek SA, et al. Among authors: neubig rr. Oncogene. 2020 Feb;39(7):1466-1483. doi: 10.1038/s41388-019-1074-1. Epub 2019 Oct 28. Oncogene. 2020. PMID: 31659259 Free PMC article.

10

RGS-Insensitive G Proteins as In Vivo Probes of RGS Function.

Neubig RR. Neubig RR. Prog Mol Biol Transl Sci. 2015;133:13-30. doi: 10.1016/bs.pmbts.2015.04.010. Epub 2015 Jun 6. Prog Mol Biol Transl Sci. 2015. PMID: 26123300 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results